AskAt received a Notice of Allowance dated February 11, 2020 from the Canadian Intellectual Property Office (CIPO) in connection with the Application No. 2,789,665, a use patent of EP4 antagonist for the treatment of IL-23 mediated diseases.
HOME > NEWS
AskAt received a Notice of Allowance dated February 11, 2020 from the Canadian Intellectual Property Office (CIPO) in connection with the Application No. 2,789,665, a use patent of EP4 antagonist for the treatment of IL-23 mediated diseases.
